ROCKETSCRIPT
LIVE

Serial Number

88018527

Owner

Bioneer Corporation

Attorney

Steven J. Hultquist

Filing Date

Jun 28, 2018

Add to watchlist:

No watchlists yet
View on USPTO

ROCKETSCRIPT Trademark

Serial Number: 88018527 • Registration: 5941246

ROCKETSCRIPT is a trademark filed by Bioneer Corporation on June 28, 2018. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Bioneer Corporation (23 trademarks)

8-11, Munpyeong Seo-ro, Daedeok-gu
Daejeon, 306-220 , KR

Entity Type: 03

Trademark Details

Filing Date

June 28, 2018

Registration Date

December 24, 2019

Published for Opposition

October 8, 2019

Goods & Services

biological enzymes for medical use; kits for use in cDNA synthesis for medical purposes comprised of reagents, buffers, reverse transcriptase, oligomer; compositions for use in nucleic acid fluorescence staining for medical purposes; kits for use in nucleic acid fluorescence staining for medical purposes consisting of reagents, buffers, staining reagents; compositions for use in DNA sequence analysis for medical purposes; kits for use in DNA sequence analysis for medical purposes consisting of reagents, buffers, DNA polymerase; nucleic acid polymerase for medical purposes; compositions for use in nucleic acid amplification for medical purposes; kits for use in nucleic acid amplification for medical purposes consisting of reagents, buffers, nucleic acid polymerase; chemical reagents for medical purposes; compositions for use in nucleic acid amplification for medical purposes; compositions for use in reverse transcription for medical purposes

biological enzymes for non-medical use; compositions for use in cDNA synthesis for research purposes; kits for use in cDNA synthesis for research purposes comprised of reagents, buffers, reverse transcriptase, oligomer; compositions for use in nucleic acid fluorescence staining for research purposes; kits for use in nucleic acid fluorescence staining for research purposes consisting of reagents, buffers, staining reagents; compositions for use in DNA sequence analysis for research purposes; kits for use in DNA sequence analysis for research purposes consisting of reagents, buffers, DNA polymerase; nucleic acid polymerase for research purposes; compositions for use in nucleic acid amplification for research purposes; kits for use in nucleic acid amplification for research purposes consisting of reagents, buffers, nucleic acid polymerase; chemical reagents for research purposes; compositions for use in polymerase chain reaction for research purposes; compositions for use in reverse transcription for research purposes

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Jun 5, 2025 NAS8
REGISTERED - SEC. 8 (6-YR) ACCEPTED
Jun 5, 2025 8.OK
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 26, 2025 APRE
TEAS SECTION 8 RECEIVED
Jan 14, 2025 ES8R
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Dec 24, 2024 REM1
REGISTERED-PRINCIPAL REGISTER
Dec 24, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 8, 2019 NPUB
PUBLISHED FOR OPPOSITION
Oct 8, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 18, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 3, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 30, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 30, 2019 CRFA
ASSIGNED TO LIE
Aug 29, 2019 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Aug 23, 2019 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Apr 24, 2019 GNS2
INQUIRY TO SUSPENSION E-MAILED
Apr 24, 2019 GNSI
SUSPENSION INQUIRY WRITTEN
Apr 24, 2019 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 22, 2018 GNS3
LETTER OF SUSPENSION E-MAILED
Oct 22, 2018 GNSL
SUSPENSION LETTER WRITTEN
Oct 22, 2018 CNSL
ASSIGNED TO EXAMINER
Oct 19, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 3, 2018 NWOS
NEW APPLICATION ENTERED
Jul 2, 2018 NWAP